Status:
COMPLETED
Study of the Kinetics of COVID-19 Antibodies for 24 Months in Patients With Confirmed SARS-CoV-2 Infection
Lead Sponsor:
Centre Hospitalier Régional d'Orléans
Collaborating Sponsors:
Institut Pasteur
Conditions:
Covid19
SARS-CoV-2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The main objective of the study is to describe the temporal curve of COVID-19 IgG and neutralizing antibodies over 24 months in an identified population of patients who presented with SARS-CoV-2 virus...
Detailed Description
Given the seriousness of the global health consequences of the COVID-19 pandemic and the difficulty of covering the world population with effective vaccination, several questions arise: * Are the ant...
Eligibility Criteria
Inclusion
- Age \> 18
- Having had a confirmed infection with CoV-2-SARS by RT-PCR and/or serology (IgM and/or IgG specific as significant)
- Being vaccinated against anti-SARS-CoV-2 (vaccine sub-study)
- Benefiting from a Social Security system
- Having consented to participate in the study
- Accepting regular follow-up for 24 months
Exclusion
- Protected person (under guardianship or trusteeship)
- Person under the protection of justice
- Person unable to express consent
Key Trial Info
Start Date :
August 27 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 7 2022
Estimated Enrollment :
187 Patients enrolled
Trial Details
Trial ID
NCT04750720
Start Date
August 27 2020
End Date
March 7 2022
Last Update
December 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Orléans
Orléans, France, 45067